Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial

1. Meric-Bernstam, F.
2. Makker, V.
3. Oaknin, A.
4. Oh, D.-Y.
5. Banerjee, S.
6. González-Martín, A.
7. Jung, K.H.
8. Ługowska, I.
9. Manso, L.
10. Manzano, A.
11. Melichar, B.
12. Siena, S.
13. Stroyakovskiy, D.
14. Fielding, A.
15. Ma, Y.
16. Puvvada, S.
17. Shire, N.
18. Lee, J.-Y.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1200/JCO.23.02005 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus